CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX;UNIVERSITE BORDEAUX SEGALEN
发明人:
LEAUTE-LABREZE CHRISTINE,DUMAS DE LA ROCHE ERIC,TAIEB ALAIN,THAMBO JEAN-BENOIT
申请号：
SI200830749
公开号：
SI2233135T1
申请日:
2008.10.16
申请国别(地区):
SI
年份:
2012
代理人:
摘要：
The present invention relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present invention provides an alternative to the known compounds, e.g. coroticosteroïds, interferon or vincristine, generally used for the treatment of hemangiomas.
